Article | Open Access | Published:

A herbal formula comprising Rosae Multiflorae Fructus and Lonicerae Japonicae Flos, attenuates collagen-induced arthritis and inhibits TLR4 signalling in rats

Scientific Reports volume 6, Article number: 20042 (2016) | Download Citation

Abstract

RL, a traditional remedy for Rheumatoid arthritis (RA), comprises two edible herbs, Rosae Multiflorae Fructus and Lonicerae Japonicae Flos. We have reported that RL could inhibit the production of inflammatory mediators in immune cells. Here we investigated the effects and the mechanism of action of RL in collagen-induced arthritis (CIA) rats. RL significantly increased food intake and weight gain of CIA rats without any observable adverse effect; ameliorated joint erythema and swelling; inhibited immune cell infiltration, bone erosion and osteophyte formation in joints; reduced joint protein expression levels of TLR4, phospho-TAK1, phospho-NF-κB p65, phospho-c-Jun and phospho-IRF3; lowered levels of inflammatory factors (TNF-α, IL-6, IL-1β, IL-17A and MCP-1 in sera and TNF-α, IL-6, IL-1β and IL-17A in joints); elevated serum IL-10 level; reinvigorated activities of antioxidant SOD, CAT and GSH-Px in the liver and serum; reduced Th17 cell proportions in splenocytes; inhibited splenocyte proliferation and activation; and lowered serum IgG level. In conclusion, RL at nontoxic doses inhibited TLR4 signaling and potently improved clinical conditions of CIA rats. These findings provide further pharmacological justifications for the traditional use of RL in RA management.

Introduction

Rheumatoid arthritis (RA), a chronic autoimmune disease, is characterized by synovitis that drives extracellular matrix degradation and consequent cartilage damage and bone erosion. Prevalent in about 1% of the world population, RA ruins the quality of life of patients1. Conventional drug treatment options do not provide satisfactory efficacy and even cause serious adverse reactions2. Safe and effective novel targeted therapeutic agents are desperately needed. Researchers are seeking new approaches based on understanding RA pathology. Molecular evidence indicates that toll-like receptors (TLRs), especially TLR4, play important pathogenic roles in RA3. Increased expression of TLR4 has been observed in cells from human RA joints4, where both exogenous and endogenous TLR4 ligands have been detected5. TLR4 initiates signals for different pathways that activate transcription factors like nuclear factor-κB (NF-κB), activator protein-1 (AP-1) and interferon regulatory factor 3 (IRF3), leading to the production of inflammatory cytokines, chemokines and tissue-destructive enzymes in synovium3. Activation of TLR4 signalling promotes the differentiation of CD4+ T cells into pathogenic Th17 effectors, driving cartilage and bone erosion6,7,8,9. TLR4 signalling also plays a role in RA by inducing auto-antigen-specific adaptive immune responses10, thereby resulting in persistent joint damage3. Attenuating TLR4 signalling pathways is believed to be beneficial in RA management11,12.

Multi-target Chinese medicines with low toxicity and high efficacy are alternative options complementary to the conventional RA drugs13. Rosae Multiflorae Fructus (dried fruits of Rosa multiflora, Yingshi in Chinese) and Lonicerae Japonicae Flos (dried flowers of Lonicera japonica, Jinyinhua in Chinese) have traditionally been prescribed by Chinese medicine practitioners for treating various inflammatory disorders including RA14,15,16. Extracts/constituents of these two herbs attenuate animal arthritis and inhibit TLR4 signalling17,18,19,20,21,22. We have previously reported that RL, a herbal formula composed of these two herbs, could inhibit various components of the TLR4 signalling pathways23,24. Therefore, here we examined if RL could improve clinical conditions in collagen-induced arthritis (CIA) rats, a model that is well established for studying human RA, and investigated the involvement of TLR4 signalling in the effects of RL.

Results

RL improved clinical arthritic conditions in CIA rats

In the present study, we investigated the in vivo efficacy of RL in CIA rats. Rats immunized with bovine type II collagen began to develop arthritis in the first week. The initial manifestation of arthritis was erythema and swelling of ankle joints, followed by the inflammation of the metatarsal and inter-phalangeal joints. Disease progression can be evaluated by measuring paw swelling volume, which is an indicator of the degree of inflammation. In order to evaluate the anti-arthritic efficacy of RL, the paw volume changes were quantified using plethysmometry. At all three doses, RL significantly ameliorated paw swelling. At the end of the experiment, more significant reductions of paw volume were observed in groups treated with RL (660 mg/kg) and indomethacin (2.5 mg/kg), a nonsteroidal anti-inflammatory drug (NSAID) used as the positive control (Fig. 1A).

Figure 1: Effects of RL on disease progression in CIA rats.
Figure 1

Male Wistar rats were immunized on day 0 and day 7 with bovine type II collagen for CIA or with vehicle. CIA rats were intragastrically (i.g.) given vehicle (saline), indomethacin (Indo), low dose of RL (RL-L), middle dose of RL (RL-M) or high dose of RL (RL-H) (n = 8 for each group) daily from days 14 to 56. (A) Average volumes of hind paws. (B) Mean arthritic score. (C) Representative photographs showing the gross features of hind paws at day 57. (D) Average daily food intake during the experimental period. (E) Changes in body weight over the experimental period. Values are the mean ± SEM (n = 8). *P < 0.05, **P < 0.01 compared with the immunized control (saline).

Overall arthritis severity in CIA rats is commonly assessed by macroscopic clinical scoring. Beginning from day 7, the arthritis score of CIA rats increased progressively and reached about 6.5 in the last week. Administration of RL significantly attenuated all clinical signs of arthritis indicated by the significant reduction in the mean arthritis score (Fig. 1B). Representative photographs showing morphological changes of hind paws of rats from different groups on day 57 are shown in Fig. 1C.

Beginning from day 21, CIA rats gained significantly less weight than the normal rats. The average food intake of CIA rats was significantly reduced. RL effectively improved the food intake and ameliorated weight loss caused by CIA. Moreover, no observable adverse reaction was found in RL-treated groups during the entire experimental period. (Fig. 1D,E).

RL attenuated the radiographic damage of CIA rats

Radiographic examination of the talocrural joints revealed tissue swelling, bone matrix resorption, osteophyte formation and bone erosion at the joint margins in CIA rats. No pathogenic change was observed in normal rats. RL markedly ameliorated soft tissue swelling and the degree of joint damage (Fig. 2A). Significant reduction in radiographic score was observed in RL-treated groups (Fig. 2B).

Figure 2: Effects of RL on the radiographs of CIA rats.
Figure 2

(A) Representative radiographs of the hind limbs showing the talocrural joints at day 57. (B) Mean radiological score of the radiographs. Values are the mean ± SEM (n = 8). *P < 0.05, **P < 0.01 compared with the immunized control (saline).

RL improved the histological parameters of CIA rats

In order to determine whether RL prevented articular destruction, talocrural joints were analysed histologically. Histological examinations showed massive infiltration of inflammatory cells, pannus invasion, cartilage damage, and subchondral bone erosion in CIA rats (Fig. 3A). Histological scores of individual groups were shown in (Fig. 3B).

Figure 3: Effects of RL on histological parameters in the talocrural joints of CIA rats.
Figure 3

(A) Representative histological observation from light microscope of the talocrural joint sections stained with H&E for inflammatory cell influx and bone destruction (magnification ×100). (B) Mean score of the histological observation. Values are the mean ± SEM (n = 8). *P < 0.05, **P < 0.01 compared with the immunized control (saline).

RL inhibited TLR4 signalling in CIA rats

In a previous study, we have demonstrated that RL could inhibit the TAK1/NF-κB, TAK1/AP-1, TBK1/IRF3 pathways in LPS-stimulated murine RAW 264.7 and human THP-1 cells. Increased expression/activities of these TLR4 signalling components (TAK1, NF-κB, AP-1 and IRF3) in CIA rats demonstrated their involvement in the pathology of CIA. RL reduced the upregulated protein levels of TLR4, phospho-TAK1, phospho-NF-κB p65, phospho-c-Jun and phospho-IRF3 in CIA joint tissues (Fig. 4A,B). Upon ligand binding, TLR4 recruits several adaptors which lead to activation of TAK1. Transcription of NF-κB, AP-1 and IRF3 initiates the production of pro-inflammatory cytokines and effector cytokines such as TNF-α, IL-1β and IL-6, which contribute to the pathogenesis of CIA. RL mitigated the upregulated levels of pro-inflammatory TNF-α, IL-1β and IL-6, while elevated the levels of anti-inflammatory IL-10 in both sera and joint tissue lysates (Figs 4C and 5A–D). RL also lowered the level of MCP-1 in sera (Fig. 5E).

Figure 4: Effects of RL on TLR4 signalling in joint tissues of CIA rats.
Figure 4

(A) Representative western blots showing the protein expression of TLR4, phospho-TAK1, phospho-NF-κB p65, phospho-c-Jun, phospho-IRF3 and β-actin (as loading control) in joint tissues. (B) Relative intensity values from band densitometry. The values are the mean ± SEM of the band density normalized to the loading control in relation to mean value of untreated control (control) normalized to the loading control (n = 8). (C) Levels of cytokines from joint tissue lysates determined by Milliplex MAP Rat Cytokine/Chemokine Panel or ELISA at the end of the experiment. Values are the mean ± SEM (n = 8). *P < 0.05, **P < 0.01 compared with the immunized control (saline).

Figure 5: Effects of RL on serum levels of cytokines and chemokines in CIA rats.
Figure 5

Serum levels of cytokines and chemokines were determined by Milliplex MAP Rat Cytokine/Chemokine Panel or ELISA at different time points. (A) Changes in serum TNF-α levels. (B) Changes in serum IL-1β levels. (C) Changes in serum IL-10 levels. (D) Changes in serum IL-6 levels. (E) Changes in serum MCP-1 levels. Values are the mean ± SEM (n = 8). *P < 0.05, **P < 0.01 compared with the immunized control (saline).

RL rejuvenated the declined activities of endogenous antioxidant enzymes in CIA rats

Activated TLR4 signalling induces oxidative stress, resulting in imbalance of antioxidant system25,26. Excessive production of pro-inflammatory mediators exaggerates the oxidative stress in RA, resulting in immune cells activation27. Since the two herbs in RL contain various natural antioxidants21,28,29, we determined the effects of RL on the activities of the endogenous antioxidant enzymes in CIA rats. RL treatment at high dose significantly rejuvenated the declined activities of the antioxidant enzymes (SOD, CAT and GSH-Px) in sera (Fig. 6A) and liver tissues of CIA rats (Fig. 6B).

Figure 6: Effects of RL on the activities of antioxidant enzymes in CIA.
Figure 6

(A) Antioxidant enzyme (SOD, CAT, and GSH-Px) activities in sera collected on day 49 after first immunization. (B) Antioxidant enzyme (SOD, CAT, and GSH-Px) activities in homogenized liver tissues at the end of the experiment. Values are the mean ± SEM (n = 8). *P < 0.05, **P < 0.01 compared with the immunized control (saline).

RL suppressed pathogenic immune responses in CIA rats

TLR4 potently instructs both innate and adaptive immune responses. Inhibition on TLR4 signalling has been shown to lower the synovial expression of IL-17 and serum concentrations of IL-17 in CIA models6,30. In order to characterize the effect of RL on TLR4-signalling-related immune responses, levels of IL-17 in joint tissues and sera were determined. RL significantly mitigated the levels of IL-17 in both sera and joint tissue lysates of CIA rats (Fig. 7A,B). Studies showed that the splenic proportion of pathogenic Th17 cells, which play an important role in the pathogenesis of RA31, correlated directly with the levels of serum IL-17 in arthritic mice32. In line with decreasing serum IL-17, RL also reduced Th17 cell proportion in splenocytes (Fig. 7C,D) and inhibited IL-17A production in PMA-and-ionomycin-activated splenocytes isolated from CIA rats (Fig. 7E). The humoral response against autoantigen is essential for the development of erosive arthritis33. RL inhibited CII-stimulated proliferation of splenocytes isolated from CIA rats (Fig. 8A) and significantly reduced the IgG antibody level in sera (Fig. 8B).

Figure 7: Effects of RL on IL-17 and Th17 cells in CIA rats.
Figure 7

(A) Levels of IL-17A from joint tissue lysates determined by Milliplex MAP Rat Cytokine/Chemokine Panel at the end of the experiment. (B) Serum levels of IL-17 determined by Milliplex MAP Rat Cytokine/Chemokine Panel at different time points. (C) Isolated splenocytes were stimulated with PMA (0.05 μg/ml) and ionomycin (1 μg/ml) for 4 h and then BFA (5 μg/ml) for additional 2 h. Cells were extracellularly stained with FITC-conjugated anti-CD4, fixed, permeabilized and labelled with PE-conjugated anti-IL-17A. Representative graphs showing the percentages of positive-stained Th17 in CD4+ cells analyzed by flow cytometry. (D) The mean percentages of positive-stained Th17 in CD4+ cells. (E) Concentration of IL-17A determined by ELISA in the supernatants of isolated splenocytes stimulated with PMA (0.05 μg/ml) and ionomycin (1 μg/ml). Values are the mean ± SEM (n = 8). *P < 0.05, **P < 0.01 compared with the immunized control (saline).

Figure 8: Effects of RL on immune responses in CIA rats.
Figure 8

(A) Splenocytes isolated from rats were stimulated with CII (50 μg/ml) and cultured for 72 h. Cell proliferation was measured by the MTT assay and expressed as mean percentage of control cells. (B) Antibody concentrations in the sera were measured by ELISA. Values are the mean ± SEM (n = 8). *P < 0.05, **P < 0.01 compared with the immunized control (saline).

Discussion

Current drug treatment options against RA like NSAID and disease-modifying anti-rheumatic drugs are not satisfactory because of their low efficacy, adverse effects and toxicity. New therapeutic agents with low toxicity and high efficacy should be explored. Researchers are seeking alternative, complementary therapeutic agents from multi-target Chinese medicines.

RL, a traditional remedy for inflammatory disorders including RA, is composed of Yingshi and Jinyinhua, which are of low toxicity. Yingshi can be used to make various food products28,34,35, and Jinyinhua is treated as food in Asian countries36. It has been shown that oral administration of an extract of Yingshi attenuated the severity of CIA rats without showing any observable adverse effects21. Jinyinhua together with other herbs have been demonstrated to improve conditions in CIA mice37. In the present study, we demonstrated that the herbal formula RL significantly improved the clinical conditions throughout the course of disease in CIA rats without observable adverse effects. These evidences support RL to be a potential safe and effective anti-RA agent.

Several studies have proposed novel strategies for the treatment of RA and CIA by regulating the activities of immune cells as well as the levels of certain cytokines (e.g. TNF-α, GMCSF, IL-17)38,39. The TLR4 signalling pathway, which regulates a wide range of proinflammatory cytokines and the activities of various immune cells, is believed to be one of the novel therapeutic targets in RA management11,12. We previously reported that RL could inhibit various TLR4 signalling components23. Therefore, we investigated RL’s effects on TLR4 signalling-related events in CIA rats, in which TLR4 can be activated by ligands from damaged synovial tissues6. Upon ligand binding, TLR4 signalling activates transcription factors NF-κB (p50/p65 heterodimer), AP-1 (c-Fos/c-Jun heterodimer) and IRF340,41. Activation of these transcription factors results in the production of inflammatory mediators e.g. IL-6, MCP-1, TNF-α and IL-1β, providing a positive feedback to the TLR4 signalling pathways, which results in persistent inflammation and favours the induction of autoimmunity42. In this study, we found that RL could inhibit TLR4 signalling. This was demonstrated by the suppressed protein expressions of TLR4, phospho-TAK1, phospho-NF-κB p65, phospho-c-Jun, and phospho-IRF3 in joint tissues. Phosphorylation of the key transcription factors of TLR4 signalling is essential to the production of pro-inflammatory cytokines. RL’s inhibition on TLR4 signalling was also evidenced by the reduced production of pro-inflammatory cytokines regulated by the transcription factors NF-κB, AP-1 and IRF3 in sera and joint tissues of CIA rats. These pro-inflammatory cytokines could induce oxidative stress, leading to declined activities of endogenous antioxidants. RL rejuvenated the declined activities of the antioxidant enzymes (SOD, CAT and GSH-Px) in sera and liver tissues of CIA rats. TLR4 signalling also takes part in immune responses43. Production of autoimmune antibodies and IL-17 upon collagen immunization was found to be less in TLR4-deficient mice than in wild type mice6. In the present study, RL was found to be able to lower the levels of IL-17 in sera and joint tissues of CIA rats. This observation was supported by the reduction of pathogenic Th17 cells and IL-17 production in spleen cells. In addition, RL could reduce the IgG antibody production and inhibit antigen-stimulated proliferation of splenocytes. These suggest that attenuation of TLR4 signalling is possibly one of the molecular mechanisms for the anti-arthritic effects of RL in CIA rats (Fig. 9). Reduction in the proportions of Th17 cells may also be responsible for the effects of RL. Several studies have demonstrated that besides the Th17 cells, modulating the activities of other immune cells (e.g. macrophages, monocytes, B cells, dendritic cells, Treg cells) may also be a potential therapeutic approach in RA management44,45,46,47. Because of the multi-component and multi-target natures of Chinese medicines, we believe that this herbal formula may also affect other immune cells. Further studies are needed to investigate the effects of this formula on other signalling pathways as well as other components of the immune system.

Figure 9: A schematic diagram showing the effects of RL in CIA rats.
Figure 9

In conclusion, RL improved the clinical conditions of CIA rats without overt adverse effects, which was associated with the inhibition of TLR4 signalling. These findings provide further pharmacological basis for the traditional use of this formula in controlling RA. Further studies should be performed to develop RL into a safe, effective and modern anti-RA agent.

Methods

Preparation of RL

The herbal material was prepared as described previously23. Briefly, 500 g Yingshi and 300 g Jinyinhua were mixed, minced, macerated with 12 L absolute ethanol for 24 h, and refluxed for 2 h twice. Supernatants were filtered, concentrated, freeze-dried and produced RL (Yield: 15.2%). To control its quality, we established an HPLC chromatogram for RL and quantified the contents of gallic acid and chlorogenic acid (Supplementary Figure 1), which is the same as the Supplementary Material of a previous report23.

Animal treatments

Male Wistar rats (140 ± 15 g) were supplied by the Chinese University of Hong Kong and housed under standard conditions (25 ± 2 °C, humidity: 60 ± 10%, 12 h-light:12 h-dark) with free access to water and chow. Forty-eight rats were randomly divided into six groups of eight. Five groups were immunized intradermally, at the base of the tail and the back, with 200 μg bovine type II collagen (Chondrex, Redmond, WA, USA) in 0.05 M acetic acid emulsified with equal volume incomplete Freund’s adjuvant (IFA) (Chondrex, Redmond, WA, USA) on day 0. A boost injection of 100 μg collagen-IFA suspension was given in the same manner on day 7. From day 14 to 56, immunized groups were intragastrically (i.g.) administered with 165, 330, 660 mg RL/kg/day, 2.5 mg indomethacin/kg/day and saline, respectively; while normal controls were i.g. administered with saline. Retro-orbital blood samplings under anaesthesia were performed at various time points. Sera were collected by centrifugation (1500 G, 20 min). At day 57, the rats were fasted overnight and killed by anaesthetic overdose. After taking radiographs of hind limbs, left paw tissues (whole joints including synovium, adjacent tissues and bones) were pulverized using a mortar and pestle filled with liquid nitrogen, and homogenized in 50 mM Tris-HCl, 1% NP-40, 0.35% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA of pH 7.4, 1 mM phenylmethylsulfonyl fluoride, 1 mM NaF, 1 mM Na3VO4, 10 μg/mL aprotinin, 10 μg/mL leupetin and 10 μg/mL pepstatin A. Right hind limbs were collected for histological examinations. Single cell suspensions of splenocytes were prepared from spleens as described6. Red blood cells in the suspensions were removed by treatment with 0.16 M Tris-NH4Cl solution. Liver tissues were dissected and homogenized in ice-cold saline using an ultra-Turrax T-25 homogenizer. The experimental protocol was approved by the Ethics Committee of Hong Kong Baptist University. All experimental procedures were conducted according to the principles expressed in the Declaration of Helsinki and the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health. Every effort was made to reduce the number of animals used and minimize their pain and distress.

Macroscopic scoring of CIA

Each hind limb was scored on a 0 ~ 4 scale: 0 = normal; 1 = mild, but definite ankle erythema and swelling, or limited to individual digits; 2 = moderate ankle erythema and swelling; 3 = entire limb erythema and swelling including digits; 4 = maximally inflamed limb with multiple joints involvement. The arthritis score was the sum of the scores of the two hind limbs (maximum: 8). To quantify oedema, hind paw volumes were measured using a plethysmometer.

Radiographic analysis

Hind limbs radiographs taken on day 57 were evaluated using a 0 ~ 3 scale (maximum: 6): 0 = normal; 1 = soft tissue swelling only; 2 = soft tissue swelling and early joint erosions; 3 = severe bone erosion or significant osteophyte formation.

Histological analysis

Right hind limbs were fixed in 4% neutral formalin for one week and then decalcified in 0.5 M EDTA and 0.5% paraformaldehyde for 20 days. Decalcified samples were dehydrated with alcohol, embedded in paraffin and sectioned (10 μ thick). Talocrural joint sections were stained with hematoxylin and eosin and mounted on glass slides for histological analysis by light microscopy. Histopathological changes of the joint were evaluated based on histologic parameters (inflammation, synovial hyperplasia, pannus formation, and erosion of cartilage/bone) using a 0 ~ 4-point scale: 0 = normal; 1 = synovium hypertrophy with cell infiltrates; 2 = pannus and cartilage erosions; 3 = major cartilage and subchondral bone erosions; 4 = loss of joint integrity and ankylosis.

Immunoblotting

The quantified joint tissue lysates were assessed by Western blot analysis as described previously23. Briefly, protein lysates were subjected to 10% SDS-PAGE and then electro-transferred onto nitrocellulose membrane. After blocking with 5% non-fat milk in TBST, the membrane was incubated with designated primary antibodies overnight. The membrane was then incubated with anti-mouse or anti-rabbit secondary antibodies48,49. The specific immunoreactive bands were detected using enhanced chemiluminescence ECL detection kit (Invitrogen, Carlsbad, CA, USA) following the manufacturer’s instruction.

Splenocytes culture

Splenocytes isolated from animals were maintained in RPMI 1640 medium containing 10% heat-inactivated foetal bovine serum (FBS) and 1% antibiotics of penicillin/ streptomycin at 37 °C under 5% CO2.

Splenocytes proliferation assay

Splenocytes suspensions (5 × 106 cells/well in 96 well plate) were cultured in RPMI 1640 medium containing 50 μg/ml heat-denatured bovine CII (pre-treated at 80 °C, 10 min) for 72 h. MTT (0.5 mg/ml) was then added for 1 h. Supernatants were removed after centrifugation (500G, 10 min), and 100 μl of DMSO were added. Absorbance at 570 nm, measured using microplate spectrophotometer, was expressed as percentage of the normal control.

Splenocytes activation assay

Splenocytes (2 × 106 cells/ml) were stimulated with PMA (0.05 μg/ml) and ionomycin (1 μg/ml) at 37 °C for 48 h. IL-17A concentrations in the supernatants were determined by ELISA (eBioscience, Inc., CA, USA) following manufacturer’s instructions.

Flow cytometric analysis

Splenocytes (2 × 106 cells/ml) were stimulated with PMA (0.05 μg/ml) and ionomycin (1 μg/ml) for 4 h and then brefeldin A (BFA, 5 μg/ml) for 2 h. Cells were extracellularly stained with FITC-conjugated anti-CD4, fixed, permeabilized, then labelled intracellularly with PE-conjugated anti-IL-17A50,51. Percentages of stained cells were measured using FACS instruments.

Cytokine, chemokine, antioxidant and anti-collagen antibody assays

Cytokine and chemokine levels were quantified by Milliplex MAP Rat Cytokine/Chemokine Panel (Merck Millipore), while antioxidants and anti-mouse CII IgG levels were determined by ELISA kits (eBioscience, Inc., CA, USA) following manufacturer’s instructions52.

Statistical analysis

The results are presented as the means ± SEM. Data were analyzed by one-way ANOVA. Comparisons between two groups were performed using the Dunnett’s multiple comparisons test or post-hoc analysis. Statistical analyses were carried out using GraphPad Prism version 5.0 (GraphPad Software, San Diego, CA, USA). P < 0.05 was considered statistically significant.

Additional Information

How to cite this article: Cheng, B. C. Y. et al. A herbal formula comprising Rosae Multiflorae Fructus and Lonicerae Japonicae Flos, attenuates collagen-induced arthritis and inhibits TLR4 signalling in rats. Sci. Rep. 6, 20042; doi: 10.1038/srep20042 (2016).

References

  1. 1.

    , , , & Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. Arthritis Rheum 63, 1182–1189 (2011).

  2. 2.

    , & Safety and efficacy of on-demand versus continuous use of nonsteroidal antiinflammatory drugs in patients with inflammatory arthritis: a systematic literature review. J Rheumatol Suppl 90, 56–58 (2012).

  3. 3.

    & Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis. Rheumatology (Oxford) 51, 7–23 (2012).

  4. 4.

    et al. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum 58, 3684–3692 (2008).

  5. 5.

    et al. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum 43, 593–598 (2000).

  6. 6.

    , , & Toll-like receptor 4 is involved in inflammatory and joint destructive pathways in collagen-induced arthritis in DBA1J mice. PLoS One 6, e23539 (2011).

  7. 7.

    & Understanding how lipopolysaccharide impacts CD4 T-cell immunity. Crit Rev Immunol 28, 281–299 (2008).

  8. 8.

    , , & Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation. Proc Natl Acad Sci USA 109, 13064–13069 (2012).

  9. 9.

    et al. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2, 947–950 (2001).

  10. 10.

    , , , & Essential roles of Toll-like receptor-4 signaling in arthritis induced by type II collagen antibody and LPS. Int Immunol 17, 325–333 (2005).

  11. 11.

    , & Negative regulatory approaches to the attenuation of Toll-like receptor signaling. Exp Mol Med 45, e11 (2013).

  12. 12.

    & The role of toll-like receptors in rheumatoid arthritis. Curr Rheumatol Rep 11, 357–364 (2009).

  13. 13.

    , , & Scientific basis of botanical medicine as alternative remedies for rheumatoid arthritis. Clin Rev Allergy Immunol 44, 284–300 (2013).

  14. 14.

    , & Earliest report of Flos Lonicerae Japonicae and its medical organ. Zhongyaocai 20, 2 (1997).

  15. 15.

    Chinese Materia Medica: Combinations and Applications. Donica Publishing Ltd. (2002).

  16. 16.

    Xiandai Shiyong Zhongyao. Yilin Shuju Press (2006).

  17. 17.

    , , , & Wound repair and anti-inflammatory potential of Lonicera japonica in excision wound-induced rats. BMC Complement Altern Med 12, 226 (2012).

  18. 18.

    et al. Anti-inflammatory activities and mechanisms of action of the petroleum ether fraction of Rosa multiflora Thunb. hips. J Ethnopharmacol 138, 717–722 (2011).

  19. 19.

    , , , & Lonicera japonica THUNB. Extract Inhibits Lipopolysaccharide-Stimulated Inflammatory Responses by Suppressing NF-kappaB Signaling in BV-2 Microglial Cells. J Med Food (2015).

  20. 20.

    et al. Anti-inflammatory effect of Lonicera japonica in proteinase-activated receptor 2-mediated paw edema. Clin Chim Acta 330, 165–171 (2003).

  21. 21.

    et al. Petroleum ether extractive of the hips of Rosa multiflora ameliorates collagen-induced arthritis in rats. J Ethnopharmacol (2014).

  22. 22.

    et al. Anti-inflammatory and analgesic effects of the ethanol extract of Rosa multiflora Thunb. hips. J Ethnopharmacol 118, 290–294 (2008).

  23. 23.

    et al. A herbal formula consisting of Rosae Multiflorae Fructus and Lonicerae Japonicae Flos inhibits inflammatory mediators in LPS-stimulated RAW 264.7 macrophages. J Ethnopharmacol (2014).

  24. 24.

    et al. A herbal formula comprising Rosae Multiflorae Fructus and Lonicerae Japonicae Flos inhibits the production of inflammatory mediators and the IRAK-1/TAK1 and TBK1/IRF3 pathways in RAW 264.7 and THP-1 cells. J Ethnopharmacol, JEPD1501687 (2015).

  25. 25.

    et al. TLR costimulation causes oxidative stress with unbalance of proinflammatory and anti-inflammatory cytokine production. J Immunol 192, 5373–5381 (2014).

  26. 26.

    et al. Toll-like receptor 4 senses oxidative stress mediated by the oxidation of phospholipids in extracellular vesicles. Sci Signal 8, ra60 (2015).

  27. 27.

    et al. Rheumatoid arthritis: the role of reactive oxygen species in disease development and therapeutic strategies. Antioxid Redox Signal 9, 1541–1567 (2007).

  28. 28.

    & Detection of vitamin C in fruits of Rosa multiflora with HPLC. Shipinyanjiu yu kaifa 29, 87–89 (2008).

  29. 29.

    , , & Evaluation of antioxidant activities of extracts from 19 Chinese edible flowers. Springerplus 3, 315 (2014).

  30. 30.

    et al. Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production. Arthritis Rheum 58, 3753–3764 (2008).

  31. 31.

    & The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy. Cytokine 74, 101–107 (2015).

  32. 32.

    Toll-like receptor 2 signaling in CD4+ T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease. Immunity 32, 692–702 (2010).

  33. 33.

    , , & Chronic development of collagen-induced arthritis is associated with arthritogenic antibodies against specific epitopes on type II collagen. Arthritis Res Ther 7, R1148–1157 (2005).

  34. 34.

    , , , & Antioxidant and antimicrobial activities of native Rosa sp. from British Columbia, Canada. Int J Food Sci Nutr 58, 178–189 (2007).

  35. 35.

    & Research development and application of edible herbal resources in Xinjiang, China. Zhongguo Shiwu Yu Yingyang 14, 13–16 (2008).

  36. 36.

    , , , & Acute and subacute toxicity study of the ethanol extract from Lonicera japonica Thunb. J Ethnopharmacol 107, 370–373 (2006).

  37. 37.

    et al. Anti-arthritic activity of Fu-Fang-Lu-Jiao-Shuang on collagen-induced arthritis in Balb/c mice and its underlying mechanisms. Pharmacogn Mag 11, 242–249 (2015).

  38. 38.

    , & Eye-mediated immune tolerance to Type II collagen in arthritis-prone strains of mice. J Cell Mol Med 18, 2512–2518 (2014).

  39. 39.

    & Type II collagen induces peripheral tolerance in BALB/c mice via the generation of CD8+ T regulatory cells. PLoS One 7, e48635 (2012).

  40. 40.

    & Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol. Rev. 233, 233–255 (2010).

  41. 41.

    & TLR signaling pathways. Semin Immunol 16, 3–9 (2004).

  42. 42.

    & Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev. Immunol 7, 429–442 (2007).

  43. 43.

    & Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol 560, 11–18 (2005).

  44. 44.

    et al. Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy. J Interferon Cytokine Res 35, 585–599 (2015).

  45. 45.

    , , & Excretory-secretory products secreted by Paragonimus westermani delay the spontaneous cell death of human eosinophils through autocrine production of GM-CSF. Int Arch Allergy Immunol 132, 48–57 (2003).

  46. 46.

    et al. GM-CSF: An immune modulatory cytokine that can suppress autoimmunity. Cytokine 75, 261–271 (2015).

  47. 47.

    et al. Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens. Infect Immun 68, 1905–1911 (2000).

  48. 48.

    , , & Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing. PLoS One 7, e50366 (2012).

  49. 49.

    et al. Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay. J Virol 88, 4353–4365 (2014).

  50. 50.

    et al. A novel pancreatic beta-cell targeting bispecific-antibody (BsAb) can prevent the development of type 1 diabetes in NOD mice. Clin Immunol 153, 187–198 (2014).

  51. 51.

    et al. The novel role of IL-7 ligation to IL-7 receptor in myeloid cells of rheumatoid arthritis and collagen-induced arthritis. J Immunol 190, 5256–5266 (2013).

  52. 52.

    , , & Inhibition of Inflammatory Response by Artepillin C in Activated RAW264.7 Macrophages. Evid Based Complement Alternat Med 2013, 735176 (2013).

Download references

Acknowledgements

This work is partially supported by grants JCYJ20120829154222473 and JCYJ20140807091945050 from the Science, Technology and Innovation Commission of Shenzhen, HKBU 262512 from the Research Grants Council of Hong Kong, HMRF11122521 from Food and Health Bureau of Hong Kong, and FRG2/14-15/056, FRG2/15-16/020 from the Hong Kong Baptist University.

Author information

Affiliations

  1. Consun Chinese Medicines Research Centre for Renal Diseases, Hong Kong Baptist University, Hong Kong

    • Brian Chi Yan Cheng
    • , Hua Yu
    • , Hui Guo
    • , Tao Su
    • , Xiu-Qiong Fu
    • , Ting Li
    • , Hui-Hui Cao
    • , Anfernee Kai-Wing Tse
    • , Hiu-Yee Kwan
    •  & Zhi-Ling Yu
  2. Centre for Cancer and Inflammation Research, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong

    • Brian Chi Yan Cheng
    • , Hua Yu
    • , Hui Guo
    • , Tao Su
    • , Xiu-Qiong Fu
    • , Ting Li
    • , Hui-Hui Cao
    • , Anfernee Kai-Wing Tse
    • , Hiu-Yee Kwan
    •  & Zhi-Ling Yu
  3. Institute of Integrated Bioinfomedicine & Translational Science, HKBU Shenzhen Research Institute and Continuing Education, Shenzhen, PRC

    • Brian Chi Yan Cheng
    • , Hua Yu
    • , Hui Guo
    • , Tao Su
    • , Xiu-Qiong Fu
    • , Ting Li
    • , Hui-Hui Cao
    • , Anfernee Kai-Wing Tse
    • , Hiu-Yee Kwan
    •  & Zhi-Ling Yu
  4. Shenzhen Institute of Geriatrics, Shenzhen, PRC

    • Zheng-Zhi Wu

Authors

  1. Search for Brian Chi Yan Cheng in:

  2. Search for Hua Yu in:

  3. Search for Hui Guo in:

  4. Search for Tao Su in:

  5. Search for Xiu-Qiong Fu in:

  6. Search for Ting Li in:

  7. Search for Hui-Hui Cao in:

  8. Search for Anfernee Kai-Wing Tse in:

  9. Search for Zheng-Zhi Wu in:

  10. Search for Hiu-Yee Kwan in:

  11. Search for Zhi-Ling Yu in:

Contributions

B.C.Y.C. and Z.L.Y. wrote the main manuscript text and B.C.Y.C. prepared all figures. All authors were involved in drafting the article or revising it critically for important intellectual content, and all authors approved the final version to be published. Study conception and design: Z.L.Y., H.Y. and Z.Z.W.; Acquisition of data: B.C.Y.C., H.Y., H.G., T.S., X.Q.F., T.L., A.K.T., H.Y.K and H.H.C.; Analysis and interpretation of data: B.C.Y.C. and Z.L.Y.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Zhi-Ling Yu.

Supplementary information

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/srep20042

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.